ID UBP16_XENTR Reviewed; 864 AA. AC Q0VA64; F7BZB4; DT 24-MAR-2009, integrated into UniProtKB/Swiss-Prot. DT 11-DEC-2013, sequence version 2. DT 27-MAR-2024, entry version 109. DE RecName: Full=Ubiquitin carboxyl-terminal hydrolase 16 {ECO:0000255|HAMAP-Rule:MF_03062}; DE EC=3.4.19.12 {ECO:0000255|HAMAP-Rule:MF_03062}; DE AltName: Full=Deubiquitinating enzyme 16 {ECO:0000255|HAMAP-Rule:MF_03062}; DE AltName: Full=Ubiquitin thioesterase 16 {ECO:0000255|HAMAP-Rule:MF_03062}; DE AltName: Full=Ubiquitin-specific-processing protease 16 {ECO:0000255|HAMAP-Rule:MF_03062}; GN Name=usp16; OS Xenopus tropicalis (Western clawed frog) (Silurana tropicalis). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Silurana. OX NCBI_TaxID=8364; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=20431018; DOI=10.1126/science.1183670; RA Hellsten U., Harland R.M., Gilchrist M.J., Hendrix D., Jurka J., RA Kapitonov V., Ovcharenko I., Putnam N.H., Shu S., Taher L., Blitz I.L., RA Blumberg B., Dichmann D.S., Dubchak I., Amaya E., Detter J.C., Fletcher R., RA Gerhard D.S., Goodstein D., Graves T., Grigoriev I.V., Grimwood J., RA Kawashima T., Lindquist E., Lucas S.M., Mead P.E., Mitros T., Ogino H., RA Ohta Y., Poliakov A.V., Pollet N., Robert J., Salamov A., Sater A.K., RA Schmutz J., Terry A., Vize P.D., Warren W.C., Wells D., Wills A., RA Wilson R.K., Zimmerman L.B., Zorn A.M., Grainger R., Grammer T., RA Khokha M.K., Richardson P.M., Rokhsar D.S.; RT "The genome of the Western clawed frog Xenopus tropicalis."; RL Science 328:633-636(2010). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RG NIH - Xenopus Gene Collection (XGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Specifically deubiquitinates 'Lys-120' of histone H2A CC (H2AK119Ub), a specific tag for epigenetic transcriptional repression, CC thereby acting as a coactivator. Deubiquitination of histone H2A is a CC prerequisite for subsequent phosphorylation at 'Ser-11' of histone H3 CC (H3S10ph), and is required for chromosome segregation when cells enter CC into mitosis. Regulates Hox gene expression via histone H2A CC deubiquitination. Prefers nucleosomal substrates. Does not CC deubiquitinate histone H2B. {ECO:0000255|HAMAP-Rule:MF_03062}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; Evidence={ECO:0000255|HAMAP-Rule:MF_03062}; CC -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_03062}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03062}. CC -!- DOMAIN: The UBP-type zinc finger binds 3 zinc ions that form a pair of CC cross-braced ring fingers encapsulated within a third zinc finger in CC the primary structure. It recognizes the C-terminal tail of free CC ubiquitin. {ECO:0000255|HAMAP-Rule:MF_03062}. CC -!- SIMILARITY: Belongs to the peptidase C19 family. USP16 subfamily. CC {ECO:0000255|HAMAP-Rule:MF_03062}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AAMC01089338; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AAMC01089339; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC121230; AAI21231.1; -; mRNA. DR RefSeq; NP_001072158.1; NM_001078690.1. DR AlphaFoldDB; Q0VA64; -. DR STRING; 8364.ENSXETP00000034348; -. DR MEROPS; C19.021; -. DR PaxDb; 8364-ENSXETP00000043701; -. DR DNASU; 447956; -. DR Ensembl; ENSXETT00000043701; ENSXETP00000043701; ENSXETG00000020255. DR GeneID; 447956; -. DR KEGG; xtr:447956; -. DR AGR; Xenbase:XB-GENE-1007164; -. DR CTD; 10600; -. DR Xenbase; XB-GENE-1007164; usp16. DR eggNOG; KOG1873; Eukaryota. DR HOGENOM; CLU_007938_1_0_1; -. DR InParanoid; Q0VA64; -. DR OrthoDB; 227085at2759; -. DR PhylomeDB; Q0VA64; -. DR TreeFam; TF326075; -. DR Reactome; R-XTR-5689880; Ub-specific processing proteases. DR Proteomes; UP000008143; Chromosome 2. DR Bgee; ENSXETG00000020255; Expressed in 2-cell stage embryo and 11 other cell types or tissues. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB. DR GO; GO:0042393; F:histone binding; ISS:UniProtKB. DR GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB. DR GO; GO:0043130; F:ubiquitin binding; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW. DR GO; GO:0016578; P:histone deubiquitination; IEA:UniProtKB-UniRule. DR GO; GO:0140014; P:mitotic nuclear division; IEA:UniProtKB-UniRule. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB. DR GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0051726; P:regulation of cell cycle; IEA:InterPro. DR CDD; cd02667; Peptidase_C19K; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 2. DR Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1. DR HAMAP; MF_03062; UBP16; 1. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR001394; Peptidase_C19_UCH. DR InterPro; IPR030849; UBP16. DR InterPro; IPR018200; USP_CS. DR InterPro; IPR028889; USP_dom. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR InterPro; IPR001607; Znf_UBP. DR PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1. DR PANTHER; PTHR21646:SF12; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 16; 1. DR Pfam; PF00443; UCH; 1. DR Pfam; PF02148; zf-UBP; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF57850; RING/U-box; 1. DR PROSITE; PS00972; USP_1; 1. DR PROSITE; PS00973; USP_2; 1. DR PROSITE; PS50235; USP_3; 1. DR PROSITE; PS50271; ZF_UBP; 1. PE 2: Evidence at transcript level; KW Activator; Cell cycle; Cell division; Chromatin regulator; Hydrolase; KW Metal-binding; Mitosis; Nucleus; Protease; Reference proteome; KW Thiol protease; Transcription; Transcription regulation; KW Ubl conjugation pathway; Zinc; Zinc-finger. FT CHAIN 1..864 FT /note="Ubiquitin carboxyl-terminal hydrolase 16" FT /id="PRO_0000367507" FT DOMAIN 196..863 FT /note="USP" FT ZN_FING 19..139 FT /note="UBP-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT REGION 162..196 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 397..497 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 162..179 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 180..196 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 402..431 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 432..450 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 205 FT /note="Nucleophile" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03062" FT ACT_SITE 798 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_03062" FT BINDING 21 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 23 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 45 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 48 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 71 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 74 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 79 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 87 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 91 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 100 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 113 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT BINDING 116 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00502" FT CONFLICT 106 FT /note="V -> M (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 405 FT /note="A -> V (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 452 FT /note="L -> Q (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 495 FT /note="I -> T (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 515 FT /note="T -> A (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 529 FT /note="L -> I (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 548 FT /note="R -> G (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 572 FT /note="V -> G (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" FT CONFLICT 714 FT /note="T -> K (in Ref. 2; AAI21231)" FT /evidence="ECO:0000305" SQ SEQUENCE 864 AA; 96666 MW; 8600F3A72FCAF9C7 CRC64; MVKKRGKNLP AQDSLDAEPV CKHLRKALDE GSVKKALVNV EWTVCQECQA DNKEKNNSDD ELVEDPSVWL CLKCGHRGCG RNSASQHALN HYNTPRSEPH CLVLSVDMWS AWCYLCDNEV PYNRSSRLGQ LVDYLQRKAK AKSKSTDSAA LDEEVKAEIV AENEVKIEDQ EEKPKGQAKW DKASSTQNNS TEPTVKGLSN LGNTCFFNAV MQNLSQTPAV RELLNEAKTL KKPVTVPLPD SSSPTNVEVH LEQQPGPLTL AMWQFLTEMQ ETKKGVVTPK EVFSQVCKKA IRFKGYQQQD SQELLRYLLD GMRGEEIQRV SLAMSKSLQN TLDEEEIKKI VKDSEKRRTI PNFVDHLFGG ELTSTIMCEE CHTVSLVHEP FLDLSLPVLD DVIVKKNSQK SSAPAPERKE EEENDDGYIK ERDEASPGAS KHLQKKAKKA AKKQAKNQRR QLKMQGKTVL LTDVAKQECS EDEEEIAPNN TESEANTRPD DEVPIADGLN TMKSDLSALE NGSETIESAM ERVTEDTDLD TSGHNTESVE MNAMELVRNM ENNNNNNTDV NKTLERTEGS GVDSMEATAA VDNGNADTVC VDDTEAANGL LDCSAASMDN ELTNSLNRLK LSSDIEPTQV EIEILPDQQQ PHTQIYEVIN EDPKTAFSTL SERKDLPLDG YSVLSCLYQF THKETLTGNN KLLCNVCTRK QASRLNNSNK GEKTFVYTNA KKQMLVSDPS PILTLHLKRF QQNGFNLRKI NRHIKFPEVL DLAPFCTSKC KNIPAGESRL LYSLYGVIEH SGSMRSGHYT AFVKLRRPNQ QLCEMVLKGV IPEVSGSEPG QGSWYHISDS HVQAVSLSRV LSSQAYLLFY ERML //